AQR Capital Management’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.1M	Sell	716,246 -97,643	-12%	-$3.2M	0.01%	1031
2025 Q4	$30.5M	Buy	813,889 +458,321	+129%	+$15.1M	0.02%	813
2025 Q3	$9.8M	Buy	355,568 +203,539	+134%	+$7.01M	0.01%	1104
2025 Q2	$4.8M	Sell	152,029 -14,311	-9%	-$460K	﹤0.01%	1309
2025 Q1	$5.52M	Buy	166,340 +7,484	+5%	+$268K	0.01%	1087
2024 Q4	$5.47M	Buy	158,856 +16,271	+11%	+$559K	0.01%	1060
2024 Q3	$5.7M	Sell	142,585 -11,760	-8%	-$413K	0.01%	993
2024 Q2	$4.66M	Buy	154,345 +1,116	+0.7%	+$33.6K	0.01%	1054
2024 Q1	$5.15M	Sell	153,229 -26,526	-15%	-$851K	0.01%	974
2023 Q4	$5.81M	Buy	179,755 +11,236	+7%	+$314K	0.01%	886
2023 Q3	$5.52M	Buy	168,519 +22,126	+15%	+$768K	0.01%	876
2023 Q2	$5.15M	Buy	146,393 +92,843	+173%	+$3.21M	0.01%	889
2023 Q1	$1.75M	Buy	53,550 +21,627	+68%	+$985K	﹤0.01%	1311
2022 Q4	$1.76M	Sell	31,923 -1,453	-4%	-$79.9K	﹤0.01%	1311
2022 Q3	$1.48M	Buy	33,376 +22,653	+211%	+$1.1M	﹤0.01%	1337
2022 Q2	$523K	Buy	+10,723	New	+$483K	﹤0.01%	1669